Company Releases - Pharmaceutical Technology

Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Advertise with us

Clinical Trials

Europe’s updated guidelines on atopic dermatitis

Trial design should give Dermira’s AD drug a better shot at Phase IIb success

Roche makes a cautious investment in Ionis’ dAMD drug

Cold Chain

Brexit backlash: EU cuts UK’s MHRA out of drug approval process

Roche’s Rituxan biosimilar woes are just beginning

Blockbuster asthma drug Xolair gains breakthrough status for food allergies

Diseases

Trial design should give Dermira’s AD drug a better shot at Phase IIb success

Roche’s Hemlibra: a (Bi)-specific shift in the hemophilia A market

Immugenyx and Janssen to develop SLE model for drug development

Drug Development

Europe’s updated guidelines on atopic dermatitis

How will the UK’s relaxed cannabis regulations impact clinical practice?

Verge Genomics: employing AI to improve drug discovery

Manufacturing

How will the UK’s relaxed cannabis regulations impact clinical practice?

Roche reports sales growth as new drugs ease pressure from biosimilar competition

Trial design should give Dermira’s AD drug a better shot at Phase IIb success

Market Data

Europe’s updated guidelines on atopic dermatitis

How will the UK’s relaxed cannabis regulations impact clinical practice?

Roche reports sales growth as new drugs ease pressure from biosimilar competition

Obsessions

NHS Genomic Medicine Service: the UK seeks to build a global genomic hub

Patient death following CAR-T therapy highlights serious manufacturing issues

Pharma Technology Focus – Special Issue